Brookfield Asset Management - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 200 filers reported holding AURINIA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.

Quarter-by-quarter ownership
Brookfield Asset Management ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$1,458,127
+17.8%
150,633
+50.6%
0.01%
+20.0%
Q1 2022$1,238,000
-82.5%
100,000
-67.7%
0.01%
-81.5%
Q4 2021$7,090,000
+560.1%
310,000
+538.9%
0.03%
+575.0%
Q3 2021$1,074,000
+75.2%
48,518
+2.6%
0.00%
+33.3%
Q2 2021$613,00047,3070.00%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 1,040,530$8,074,5132.72%
NEA Management Company, LLC 3,969,834$30,845,6102.38%
TANG CAPITAL MANAGEMENT LLC 750,000$5,827,5000.82%
ARMISTICE CAPITAL, LLC 6,048,000$46,992,9600.72%
IRONWOOD INVESTMENT MANAGEMENT LLC 95,990$745,8420.46%
Antara Capital LP 639,700$4,970,4690.44%
HighMark Wealth Management LLC 59,999$466,1920.39%
Artal Group S.A. 1,000,000$7,7700.33%
Jackson Creek Investment Advisors LLC 97,513$7580.32%
AlphaCentric Advisors LLC 50,000$388,5000.22%
View complete list of AURINIA PHARMACEUTICALS INC shareholders